Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fenghan granules is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Guangdong Provincial Hospital of Chinese Medicine. It is specifically indicated for the treatment of post-infectious cough (PIC) characterized by the 'wind-cold attacking the lung' pattern. The granules represent a modern pharmaceutical formulation of the traditional Fenghan decoction, aimed at providing a more convenient administration route for patients. In clinical trials, it is being evaluated for its efficacy in reducing cough frequency and severity compared to traditional decoctions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fenghan granules.